| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | その他(不明) |
| 表題 | Therapeutic potential of photoimmunotherapy in solid tumors expressing CD98 heavy chain. |
| 掲載誌名 | 正式名:Scientific reports 略 称:Sci Rep ISSNコード:20452322/20452322 |
| 掲載区分 | 国外 |
| 巻・号・頁 | pp.Online ahead of print |
| 著者・共著者 | Citra R A P Palangka, Naoya Kondo, Ayaka Kanai, Hirofumi Hanaoka |
| 発行年月 | 2026/06 |
| 概要 | Near-infrared photoimmunotherapy (NIR-PIT) is an emerging targeted cancer therapy that uses an antibody-photoabsorber conjugate. In this study, we evaluated the therapeutic potential of NIR-PIT targeting CD98 heavy chain (CD98hc), a transmembrane glycoprotein that is highly expressed in various solid tumors and is associated with poor prognosis. We prepared a conjugate of the clinically tested anti-CD98hc antibody IGN523 and photoabsorber IRDye700DX (IGN523-IR700). The therapeutic efficacy was assessed in vitro using four CD98hc-expressing cancer cell lines and in an in vivo tumor xenograft mouse model. In vitro, IGN523-IR700 binds to cancer cells and induces rapid and light dose-dependent cell death upon near-infrared light exposure. In the in vivo model, intravenous administration of IGN523-IR700 followed by tumor-directed light irradiation resulted in significant tumor growth inhibition compared with that in the control groups. These results demonstrate that CD98hc is a viable and effective target for NIR-PIT. Given its widespread expression, targeting CD98hc may significantly broaden the applicability of NIR-PIT to diverse cancer types. |
| DOI | 10.1038/s41598-026-57005-3 |
| PMID | 42265301 |